The Approach
We can integrate our multi-disciplinary, in-house preclinical research capabilities with yours to bring new perspectives on your cell and gene therapy candidates. When time is of the essence, our R&D services can accelerate the preclinical development of your product, whether it be a CAR-T oncology product, NK-based immunotherapy, or other cell-based modality.
Primary Screening
- Protein production
- ELISA
- Flow cytometry
Cell Line Generation
- Transcriptional reporters
- Target cell lines for cytotoxicity
Process Establishment
- Designing for manufacturability
Characterization and Potency
- Cell Phenotype
- Cell-based assays
- Cytokine release
R&D
Our Discovery Lab in Covina, CA is the nexus of our R&D support activities. Our capabilities include primary T cell culture and engineering, cell-based and immunoassays, flow cytometry, stable cell line development, and cloning. It serves as a gateway to partner early with our clients in their drug development pipeline. Our dedicated staff of scientists bring forth their experiences at the top research universities, cancer institutes, and CGT companies in the US and UK to accelerate your research and development program.